Total Payments
$108,647
2024 Payments
$198.63
Companies
19
Transactions
244
Medicare Patients
2,390
Medicare Billing
$172,811
Payment Breakdown by Category
Other$49,160 (45.2%)
Consulting$41,530 (38.2%)
Food & Beverage$9,619 (8.9%)
Travel$7,837 (7.2%)
Research$500.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,530 | 33 | 38.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,420 | 14 | 24.3% |
| Honoraria | $22,740 | 18 | 20.9% |
| Food and Beverage | $9,619 | 152 | 8.9% |
| Travel and Lodging | $7,837 | 26 | 7.2% |
| Unspecified | $500.00 | 1 | 0.5% |
Payments by Type
General
$108,147
243 transactions
Research
$500.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $32,614 | 55 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15,652 | 21 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $13,468 | 23 | $0 (2021) |
| Dompe US, Inc. | $12,900 | 24 | $0 (2022) |
| Sight Sciences, Inc. | $9,283 | 34 | $0 (2022) |
| Oyster Point Pharma, Inc. | $6,121 | 19 | $0 (2023) |
| Allergan, Inc. | $5,043 | 21 | $0 (2022) |
| Glaukos Corporation | $2,558 | 8 | $0 (2021) |
| Johnson & Johnson Surgical Vision, Inc. | $2,000 | 2 | $0 (2019) |
| TissueTech, Inc. | $1,828 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $198.63 | 3 | SUN PHARMACEUTICAL INDUSTRIES INC. ($198.63) |
| 2023 | $500.00 | 1 | Oyster Point Pharma, Inc. ($500.00) |
| 2022 | $9,838 | 30 | Oyster Point Pharma, Inc. ($5,621) |
| 2021 | $16,930 | 35 | Kala Pharmaceuticals, Inc. ($10,535) |
| 2020 | $11,517 | 21 | Dompe US, Inc. ($6,160) |
| 2019 | $34,795 | 81 | Shire North American Group Inc ($12,216) |
| 2018 | $18,800 | 41 | Shire North American Group Inc ($8,647) |
| 2017 | $16,069 | 32 | Shire North American Group Inc ($11,751) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $104.17 | General |
| 09/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $41.28 | General |
| 09/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $53.18 | General |
| 04/25/2023 | Oyster Point Pharma, Inc. | — | — | In-kind items and services | $500.00 | Research |
| Study: SAFETY ADHERENCE AND DISCONTINUATION IN VARENICLINE SOLUTION NASAL SPRAY CLINICAL TRIALS FOR DRY EYE DISEASE | ||||||
| 11/16/2022 | Dompe US, Inc. | OXERVATE (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/08/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: DRY EYE | ||||||
| 10/27/2022 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/26/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | Cash or cash equivalent | $133.36 | General |
| Category: Ophthalmology | ||||||
| 10/24/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: DRY EYE | ||||||
| 10/17/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: DRY EYE | ||||||
| 10/17/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: DRY EYE | ||||||
| 10/12/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $118.77 | General |
| Category: DRY EYE | ||||||
| 10/04/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: DRY EYE | ||||||
| 09/22/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: DRY EYE | ||||||
| 09/15/2022 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/15/2022 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/13/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: DRY EYE | ||||||
| 08/25/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: DRY EYE | ||||||
| 08/03/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: DRY EYE | ||||||
| 07/25/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | Cash or cash equivalent | $29.56 | General |
| Category: Ophthalmology | ||||||
| 07/18/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: DRY EYE | ||||||
| 06/30/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $113.02 | General |
| Category: DRY EYE | ||||||
| 06/17/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $79.32 | General |
| Category: DRY EYE | ||||||
| 06/17/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $41.97 | General |
| Category: Ophthalmology | ||||||
| 06/16/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $149.08 | General |
| Category: DRY EYE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SAFETY ADHERENCE AND DISCONTINUATION IN VARENICLINE SOLUTION NASAL SPRAY CLINICAL TRIALS FOR DRY EYE DISEASE | Oyster Point Pharma, Inc. | $500.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 688 | 984 | $303,453 | $54,657 |
| 2021 | 14 | 942 | 1,274 | $369,749 | $68,153 |
| 2020 | 10 | 760 | 1,099 | $278,148 | $50,001 |
Total Patients
2,390
Total Services
3,357
Medicare Billing
$172,811
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 323 | 577 | $151,751 | $29,218 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 151 | 157 | $60,916 | $11,717 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 40 | 40 | $21,200 | $4,189 | 19.8% |
| 68761 | Closure of tear duct opening using plug | Facility | 2022 | 22 | 42 | $26,187 | $3,334 | 12.7% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 37 | 37 | $14,911 | $1,822 | 12.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 27 | 27 | $8,775 | $1,614 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 11 | $6,292 | $977.30 | 15.5% |
| 92134 | Imaging of retina | Facility | 2022 | 34 | 43 | $6,321 | $825.52 | 13.1% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 24 | 27 | $3,834 | $571.31 | 14.9% |
| 92133 | Imaging of optic nerve | Facility | 2022 | 19 | 23 | $3,266 | $390.42 | 12.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 322 | 608 | $144,244 | $31,408 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 111 | 117 | $41,748 | $8,683 | 20.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2021 | 130 | 137 | $55,211 | $7,175 | 13.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 43 | 43 | $22,340 | $4,589 | 20.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2021 | 97 | 111 | $29,637 | $4,356 | 14.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 54 | 54 | $17,235 | $3,410 | 19.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2021 | 43 | 43 | $21,500 | $3,035 | 14.1% |
| 68761 | Closure of tear duct opening using plug | Facility | 2021 | 12 | 18 | $14,007 | $1,761 | 12.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 11 | $6,160 | $1,319 | 21.4% |
| 92134 | Diagnostic imaging of retina | Facility | 2021 | 43 | 50 | $7,350 | $935.13 | 12.7% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Facility | 2021 | 29 | 33 | $4,686 | $669.30 | 14.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 19 | 21 | $2,777 | $499.80 | 18.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2021 | 17 | 17 | $2,414 | $288.00 | 11.9% |
| 92285 | Photography of content of eyes | Facility | 2021 | 11 | 11 | $440.00 | $25.20 | 5.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 317 | 634 | $128,702 | $24,018 | 18.7% |
About Dr. Scott Hauswirth, OD
Dr. Scott Hauswirth, OD is a Corneal and Contact Management healthcare provider based in Bloomington, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417942665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Hauswirth, OD has received a total of $108,647 in payments from pharmaceutical and medical device companies, with $198.63 received in 2024. These payments were reported across 244 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($41,530).
As a Medicare-enrolled provider, Hauswirth has provided services to 2,390 Medicare beneficiaries, totaling 3,357 services with total Medicare billing of $172,811. Data is available for 3 years (2020–2022), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Corneal and Contact Management
- Location Bloomington, MN
- Active Since 09/14/2005
- Last Updated 03/25/2013
- Taxonomy Code 152WC0802X
- Entity Type Individual
- NPI Number 1417942665
Products in Payments
- XIIDRA (Drug) $32,656
- EYSUVIS (Drug) $12,267
- TearCare (Device) $8,316
- Oxervate (Drug) $7,472
- CEQUA (cyclosporine ophthalmic solution) 0.09% (Drug) $6,375
- CEQUA (Drug) $5,763
- TYRVAYA (Drug) $5,621
- OXERVATE (Drug) $2,603
- Prokera (Device) $1,828
- Cequa (Drug) $1,813
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $1,533
- Eye Health (Device) $1,438
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $1,354
- VUITY (Drug) $1,312
- Flarex (Drug) $1,000
- Tecnis Symfony IOL (Device) $1,000
- LUMIGAN (Drug) $972.07
- DAILIES (Device) $927.53
- TearCare SmartLid (Device) $895.18
- TEPEZZA (Drug) $876.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Corneal and Contact Management Doctors in Bloomington
Dr. Mark Buboltz, O.d, O.D
Corneal and Contact Management — Payments: $4,940
Corneal and Contact Management $4,940
Joselyn Dlouhy, O.d, O.D
Corneal and Contact Management — Payments: $1,679
Corneal and Contact Management $1,679
Mona Fahmy, Od, OD
Corneal and Contact Management — Payments: $658.36
Corneal and Contact Management $658.36
Dr. Tara Barth, O.d, O.D
Corneal and Contact Management — Payments: $651.75
Corneal and Contact Management $651.75
Sonja Iverson-Hill, O.d, O.D
Corneal and Contact Management — Payments: $423.78
Corneal and Contact Management $423.78
Dr. Perry Sampanis, O.d, O.D
Corneal and Contact Management — Payments: $214.79
Corneal and Contact Management $214.79